Crispr Therapeutics shares owned by Deuterium Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Deuterium Capital Management
from 13F filings
Historical chart of Deuterium Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Deuterium Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Deuterium Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.2M | 25k | 47.57 |
| 2022-03-31 | $1.1M | 18k | 62.78 |
| 2021-12-31 | $1.4M | 18k | 75.78 |
More positions owned by Deuterium Capital Management
View all positions for Deuterium Capital Management